Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer.
Koundouros N, Poulogiannis G. · 2018
Read Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer. by Koundouros N, Poulogiannis G. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5968394.txt.
Introduction
Koundouros and Poulogiannis review PI3K/Akt signalling and redox metabolism in cancer. Their review appeared in Frontiers in Oncology. Cancer cells rewire metabolism and produce reactive oxygen species. The PI3K/Akt pathway sits at the hub of these processes. It is among the most often faulty pathways in cancer. The authors examine how it drives oxidant production. Mitochondria and NADPH oxidases both play a part.
Reactive species can switch off phosphatases and spark tumour signals, they note. PI3K/Akt activity also helps cancer cells keep redox balance. That balance gives them a survival edge. The review closes with ways to exploit redox faults. Combination therapies may beat drug resistance in such tumours.
Catalog record
| CREATOR | Koundouros N, Poulogiannis G. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer By Nikos Koundouros, George Poulogiannis Published in: Frontiers in Oncology DOI: 10.3389/fonc.2018.00160 ABSTRACT Abstract Metabolic rewiring and the consequent production of reactive oxygen species (ROS) are necessary to promote tumorigenesis. At the nexus of these cellular processes is the aberrant regulation of oncogenic signaling cascades such as the phosphoinositide 3-kinase and AKT (PI3K/Akt) pathway, which is one of the most frequently dysregulated pathways in cancer. In this review, we examine the regulation of ROS metabolism in the context of PI3K-driven tumors with particular emphasis on four main areas of research. (1) Stimulation of ROS production through direct modulation of mitochondrial bioenergetics, activation of NADPH oxidases (NOXs), and metabolic byproducts associated with hyperactive PI3K/Akt signaling. (2) The induction of pro-tumorigenic signaling cascades by ROS as a consequence of phosphatase and tensin homolog and receptor tyrosine phosphatase redox-dependent inactivation. (3) The mechanisms through which PI3K/Akt activation confers a selective advantage to cancer cells by maintaining redox homeostasis. (4) Opportunities for therapeutically exploiting redox metabolism in PIK3CA mutant tumors and the potential for implementing novel combinatorial therapies to suppress tumor growth and overcome drug resistance. Further research focusing on the multi-faceted interactions between PI3K/Akt signaling and ROS metabolism will undoubtedly contribute to novel insights into the extensive pro-oncogenic effects of this pathway, and the identification of exploitable vulnerabilities for the treatment of hyperactive PI3K/Akt tumors. Keywords: reactive oxygen species, cancer, phosphoinositide 3-kinase/Akt signaling, oxidative stress, metabolism INTRODUCTION Tumorigenesis is a multi-step process involving the complex interplay of several biological processes that are highly dependent on the activation of pro-proliferative and pro-survival signaling cascades, accumulation of genetic aberrations, and adaptation to various microenvironmental stress conditions (1, 2). Underpinning these tumorigenic processes is the ability of cancer cells to alter their metabolism to promote nutrient synthesis or scavenging to support their high proliferation demands (3, 4). A major consequence of such extensive metabolic rewiring is the production of reactive oxygen species (ROS), which include both free radical molecules such as superoxide (O2•−) and hydroxyl radicals (·OH), as well as non-free radical species, of which hydrogen peroxide (H2O2) is among the most prominent (5). Although elevated ROS levels can have detrimental consequences on cell viability through extensive damage of proteins, DNA, and organelles, the concomitant increase in antioxidant and detoxification capacities in cancer cells allows for redox homeostasis, thus generating a tightly regulated system whereby ROS can promote tumorigenesis and cancer progression (6, 7). Specifically, there is renewed interest in examining the implications of redox balance on cancer cell proliferation and survival through the regulation of key signaling cascades such as the phosphoinositide 3-kinase and AKT (PI3K/Akt) pathway, which is of particular relevance as it controls many hallmarks of cancer (1, 8, 9). In this review, we will examine the emerging relationship between redox homeostasis and PI3K/Akt signaling, and discuss how their cross-regulation may promote cancer pathogenesis. In addition, we present and look with optimism opportunities toward a future therapeutic exploitation of redox homeostasis in tumors with enhanced PI3K/Akt activation. THE PI3K/AKT PATHWAY AT A GLANCE The intricacies of PI3K/Akt signaling have been extensively reviewed previously (10–12), and will only be briefly introduced here. Activation of receptor tyrosine kinases (RTKs) or G-protein-coupled receptors facilitate the recruitment of class I PI3Ks which phosphorylate phosphatidylinositol-(4,5) bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3). Oncogenic mutations in PIK3CA—the gene encoding the class I PI3K catalytic subunit p110α—are found in approximately one-third of human cancers and 40% of breast cancers (13, 14). The accumulation of PIP3 allows for the localization of AKT to the plasma membrane and its subsequent activation following phosphorylation on serine 473 and threonine 308 by mTORC2 and PDK1, respectively. Negative regulation of the PI3K/Akt pathway is largely mediated by the phosphatase and tensin homolog (PTEN) through dephosphorylation of PIP3 to PIP2. AKT is an important downstream effector of oncogenic PI3K signaling and regulates several pathways, including inhibition of apoptosis, stimulation of mTORC1-dependent cell growth, and modulation of cellular metabolism (11). Glucose and glutamine are considered as essential nutrients for cancer cell proliferation, and PI3K/Akt signaling has been shown to regulate the cellular metabolism of both nutrients. Specifically, AKT may directly increase glucose uptake through activation of the glucose transport receptor GLUT1, and stimulate glycolysis by phosphorylating hexokinase 2 (11, 15). Moreover, activating mutations in PIK3CA render colorectal cancer cells more dependent on glutamine anaplerosis to replenish TCA cycle intermediates through upregulation of glutamate pyruvate transaminase 2, and glutamine deprivation significantly reduces the proliferation of PIK3CA mutant, but not wild type, cancer cells (16). Later work has also demonstrated the importance of Akt-independent signaling cascades associated with PI3K activation, with a particular focus on serum and glucocorticoid-regulated kinases (SGKs) (17). REGULATION OF ROS PRODUCTION BY PI3K/AKT SIGNALING Aberrant PI3K/Akt signaling drives many of the molecular mechanisms contributing to increased ROS levels through direct modulation of mitochondrial bioenergetics and activation of NADPH oxidases (NOXs), or indirectly through the production of ROS as a metabolic by-product (Figure 1) (6, 18). Mitochondria are a major source of cellular ROS, and these are largely derived from electron leakage at complexes I and III of the electron transport chain (6, 19). Complex I in particular has been shown to generate ROS through two mechanisms: the first involves reduction of O2 by flavin mononucleotide following binding of NADH induced by high NADH/NAD+ ratios, and the second is through reverse electron transport whereby excessive NADH is produced following reduction of NAD+ from ubiquinol (6, 20). Interestingly, AKT has been shown to translocate to the mitochondrial matrix and inner membrane in a PI3K-dependent manner following IGF-1 stimulation (21). AKT may directly phosphorylate mitochondrial GSK-3β, reducing its activity and thus alleviating the negative regulation imposed on pyruvate dehydrogenase and α-ketoglutarate dehydrogenase complexes, which have been reported to generate superoxide and H2O2 (19, 22, 23). [Figure: Schematic representation of the interplay between PI3K/Akt signaling and redox stress. Activation of PI3K/Akt signaling occurs following stimulation of receptor tyrosine kinases (RTKs) or G-protein-coupled receptors. AKT is an important oncogenic effector of PI3K signaling and positively regulates reactive oxygen/nitrogen species (ROS/RNS) production through direct modulation of mitochondrial bioenergetics and activation of NADPH oxidases. Cellular ROS levels can also potentiate the PI3K cascade by directly activating AKT, stimulating RTKs through SNO, or through inhibition of various tumor suppressor proteins such as PTEN and PTPs. Moreover, elevated ROS levels promote the nuclear translocation of NF-κβ and HIF1-α which transcriptionally regulate several genes involved in cancer cell growth, proliferation, and survival. Abbreviations: PTP, protein tyrosine phosphatase; SNO, S-nitrosylation; O2•−, superoxide; H2O2, hydrogen peroxide; NO, nitric oxide; eNOS, endothelial nitric oxide synthase; Ub, ubiquitin; PDHC, pyruvate dehydrogenase complex; KGDH, alpha-ketoglutarate dehydrogenase; PTEN, phosphatase and tensin homolog; PI3K, phosphoinositide 3-kinase.] The activation of NOXs by PI3K/Akt signaling also contributes to higher ROS levels in cancer cells (Figure 1) (18). There are seven members of the NOX enzyme family (NOX1-5, DUOX1, and DUOX2) that are expressed across several tissue types including the liver, lung, and gastrointestinal tract (24). NOXs are composed of different subunits including p67phox, p47phox, p40phox, p22phox, RAC1, RAC2, and NOXO1/NOXA1 which facilitate the localization of the enzyme complex to the cytoplasm or plasma membrane (24). The main function of NOX enzymes was first ascertained in phagocytes as